共 10 条
[1]
BAIK KU, 1997, Z ARCH PHARM MED CHE, V330, P377
[2]
Jin GZ, 1998, ARCH PHARM, V331, P380, DOI 10.1002/(SICI)1521-4184(199812)331:12<380::AID-ARDP380>3.0.CO
[3]
2-V
[4]
EUKARYOTIC DNA TOPOISOMERASES - 2 FORMS OF TYPE-I DNA TOPOISOMERASES FROM HELA-CELL NUCLEI
[J].
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES,
1981, 78 (06)
:3487-3491
[5]
LIU LF, 1983, J BIOL CHEM, V258, P5365
[6]
Maliepaard M, 1996, ANTI-CANCER DRUG DES, V11, P403
[7]
TERADA A, 1987, B CHEM SOC JPN, V60, P203
[8]
THAYER P S, 1971, Cancer Chemotherapy Reports, V2, P1
[10]
ZHENG XG, IN PRESS ARCH PHARM

